Evidence map›Paper›PMID 29776921›Full record

Observational studyBMJ open2018

Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational study.

Jocelyn Chan, Cattram D Nguyen, Jana Y R Lai, Eileen M Dunne, Ross Andrews, Christopher C Blyth, Siddhartha Datta, Kim Fox, Rebecca Ford, Jason Hinds and 14 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Article
  15. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonization and Invasive Disease in Cambodian Children.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 12 countries.

Jocelyn ChanPneumococcal Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0002-8536-2048
Cattram D NguyenPneumococcal Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Jana Y R LaiPneumococcal Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Eileen M DunnePneumococcal Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Ross AndrewsGlobal & Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia.
Christopher C BlythSchool of Medicine, University of Western Australia, Perth, Australia.
Siddhartha DattaWorld Health Organization, Vientiane, Lao People's Democratic Republic.
Kim FoxRegional Office for the Western Pacific, World Health Organization, Manila, Philippines.
Rebecca FordInfection and Immunity Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands, Papua New Guinea.
Jason HindsInstitute for Infection and Immunity, St George's, University of London, London, UK.
Sophie La VincentePneumococcal Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Deborah LehmannWesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Australia.
Ruth LimPneumococcal Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Tuya MungunNational Center of Communicable Diseases (NCCD), Ministry of Health, Ulaanbaatar, Mongolia.
Paul N NewtonCentre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
Rattanaphone PhetsouvanhCentre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
Willam S PomatInfection and Immunity Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands, Papua New Guinea.
Anonh XeuatvongsaNational Immunization Programme, Ministry of Health, Vientiane, Lao People's Democratic Republic.
Claire von MollendorfPneumococcal Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
David A B DanceLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMHWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People's Democratic Republic.
Catherine SatzkePneumococcal Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Kim MuhollandPneumococcal Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Fiona M RussellPneumococcal Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
PneuCAPTIVE Protocol Group
The University of Melbourne · AUMahosot Hospital · LAMurdoch Children's Research Institute · AUThe Kids Research Institute Australia · AUAustralian National University · AUInstitute of Infection and Immunity · CALondon School of Hygiene & Tropical Medicine · GBNational Center for Communicable Diseases · MNNational Center for Immunization and Respiratory Diseases · USSt George's, University of London · GBThe University of Western Australia · AUWorld Health Organization - Pakistan · PKWorld Health Organization Regional Office for the Western Pacific · PH

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionPneumococcal conjugate vaccines (PCVs) prevent disease through both direct protection of vaccinated individuals and indirect protection of unvaccinated individuals by reducing nasopharyngeal (NP) carriage and transmission of vaccine-type (VT) pneumococci. While the indirect effects of PCV vaccination are well described, the PCV coverage required to achieve the indirect effects is unknown. We will investigate the relationship between PCV coverage and VT carriage among undervaccinated children using hospital-based NP pneumococcal carriage surveillance at three sites in Asia and the Pacific. METHODS AND ANALYSIS: We are recruiting cases, defined as children aged 2-59 months admitted to participating hospitals with acute respiratory infection in Lao People's Democratic Republic, Mongolia and Papua New Guinea. Thirteen-valent PCV status is obtained from written records. NP swabs are collected according to standard methods, screened using ETHICS AND DISSEMINATION: Ethical approval has been obtained from the relevant ethics committees at participating sites. The results are intended for publication in open-access peer-reviewed journals and will demonstrate methods suitable for low- and middle-income countries to monitor vaccine impact and inform vaccine policy makers about the PCV coverage required to achieve indirect protection.

Indexed as

Carrier StateChild, PreschoolDeveloping CountriesFemaleHeptavalent Pneumococcal Conjugate VaccineHumansInfantLaosLogistic ModelsMaleMongoliaNasopharynxPapua New GuineaPneumococcal InfectionsProspective StudiesResearch DesignHeptavalent Pneumococcal Conjugate Vaccinepublic healthrespiratory infections

Identifiers

PMID29776921
PMCPMC5961565
OpenAlexW2804558326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.